Kraig Biocraft Laboratories, Inc.
KBLB
$0.0798
-$0.0002-0.25%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.61M | -3.49M | -3.40M | -3.87M | -3.99M |
| Total Depreciation and Amortization | 121.70K | 91.50K | 92.50K | 100.50K | 48.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -113.60K | 767.90K | 736.20K | 1.32M | 1.51M |
| Change in Net Operating Assets | 886.60K | 847.60K | 731.10K | 794.70K | 848.60K |
| Cash from Operations | -1.72M | -1.78M | -1.84M | -1.65M | -1.58M |
| Capital Expenditure | -8.00K | -4.20K | -4.20K | 0.00 | -6.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 147.20K | -- | -- | 0.00 | 1.73M |
| Cash from Investing | 139.30K | -4.20K | -4.20K | 0.00 | 1.72M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.20K | -20.20K | -35.20K | -50.20K | -60.00K |
| Issuance of Common Stock | 856.40K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.00K | 158.20K | -- | -- | -- |
| Cash from Financing | 841.10K | 138.00K | -35.20K | -50.20K | -60.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -736.10K | -1.65M | -1.88M | -1.70M | 84.70K |